At 10 days the primary efficacy measure (a composite of asymptomatic proximal DVT, symptomatic DVT, symptomatic non-fatal PE, and VTE-related death) had occurred in 2.7% of patients in each group.

FORBES: Xarelto Effective In Medically Ill Patients But At High Bleeding Cost